-+ 0.00%
-+ 0.00%
-+ 0.00%

According to people familiar with the matter, Syngenta Group's planned initial public offering of 5 billion US dollars in Hong Kong is facing delays until the agricultural market environment improves. People familiar with the matter said that Syngenta's consulting team currently believes that it is more likely to go public in 2027. Since the relevant information has not been made public, people familiar with the matter requested anonymity. According to people familiar with the matter, Syngenta previously planned to submit a listing application in June and hopes to go public sometime this year. They said that currently the company plans to wait until September or later to submit listing documents, which means the IPO may be postponed until next year. People familiar with the matter said that related discussions are still ongoing, and the details of the schedule may still be adjusted. A Syngenta spokesperson said that the company will continue to evaluate capital market strategies based on the market environment and other factors, and plans to return to the capital market at the right time.

Zhitongcaijing·07/16/2026 04:09:03
Listen to the news
According to people familiar with the matter, Syngenta Group's planned initial public offering of 5 billion US dollars in Hong Kong is facing delays until the agricultural market environment improves. People familiar with the matter said that Syngenta's consulting team currently believes that it is more likely to go public in 2027. Since the relevant information has not been made public, people familiar with the matter requested anonymity. According to people familiar with the matter, Syngenta previously planned to submit a listing application in June and hopes to go public sometime this year. They said that currently the company plans to wait until September or later to submit listing documents, which means the IPO may be postponed until next year. People familiar with the matter said that related discussions are still ongoing, and the details of the schedule may still be adjusted. A Syngenta spokesperson said that the company will continue to evaluate capital market strategies based on the market environment and other factors, and plans to return to the capital market at the right time.